NeoGenomics, Inc. - Common Stock (NQ:NEO)
Price and Volume
Detailed Quote| Volume | 37,520 |
| Open | 16.49 |
| Bid (Size) | 16.47 (300) |
| Ask (Size) | 16.68 (200) |
| Prev. Close | 16.66 |
| Today's Range | 16.45 - 16.57 |
| 52wk Range | 7.065 - 20.15 |
| Shares Outstanding | 122,816,314 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
18.0% below 52-week high
16.52
7.0752W Low
20.1552W High
1 Week
2.7% below 1-week high
15.411W Low
16.981W High
NeoGenomics, Inc. - Common Stock (NEO) traded between $7.07 and $20.15 over the past 52 weeks and last traded at $16.52, 18.0% below its 52-week high. Over the past week it ranged between $15.41 and $16.98.
Past 12 Months
+3.5%
-10.2%
+16.1%
+97.9%
+40.5%
+76.9%
1W
+$0.55
1M
-$1.89
3M
+$2.29
6M
+$8.17
YTD
+$4.76
1Y
+$7.18
NEO was +76.9% over the past year, +97.9% over six months, +40.5% year to date, +3.5% in the last week.
12 Months vs Market
NEO
+76.9%
DIA
+11.9%
SPY
+16.9%
QQQ
+22.6%
IWM
+12.1%
Over the past 12 months NEO returned +76.9% versus DIA (Dow) +11.9%, SPY (S&P 500) +16.9%, QQQ (Nasdaq 100) +22.6% and IWM (Russell 2000) +12.1%.
Volume & Liquidity
0.02× 3-mo avg
Today 37,520
3-mo avg 2.4M
1W
2.3M
1M
2.5M
3M
2.4M
6M
2.5M
YTD
2.3M
1Y
2.4M
NEO most recently traded 37,520 shares against a 3-month average daily volume of 2.4M.
More News
Read More
Why NeoGenomics (NEO) Stock Is Up Today
October 06, 2026
Via StockStory
Topics
Regulatory Compliance
From NeoGenomics, Inc.
Via Business Wire
3 Healthcare Stocks We’re Skeptical Of
September 23, 2026
Via StockStory
3 Reasons NEO is Risky and 1 Stock to Buy Instead
September 22, 2026
Via StockStory
Via MarketBeat
1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down
September 18, 2026
Via StockStory
Topics
Economy
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
September 01, 2026
From NeoGenomics, Inc.
Via Business Wire
3 Unprofitable Stocks Walking a Fine Line
August 21, 2026
Via StockStory
3 Stocks Under $50 with Open Questions
August 06, 2026
Via StockStory
3 Healthcare Stocks with Questionable Fundamentals
August 03, 2026
Via StockStory
Why NeoGenomics (NEO) Stock Is Up Today
July 29, 2026
Via StockStory
Via StockStory
NeoGenomics Q2 Earnings Call Highlights ↗
July 28, 2026
Via MarketBeat
Topics
Earnings
NeoGenomics’s (NASDAQ:NEO) Q2 CY2026: Beats On Revenue
July 28, 2026
Via StockStory
NeoGenomics Reports Second Quarter 2026 Results
July 28, 2026
From NeoGenomics, Inc.
Via Business Wire
Via StockStory
Topics
Artificial Intelligence
1 Momentum Stock with Solid Fundamentals and 2 We Avoid
July 23, 2026
Via StockStory
From NeoGenomics, Inc.
Via Business Wire
3 Small-Cap Stocks with Questionable Fundamentals
July 15, 2026
Via StockStory
NeoGenomics (NEO) Stock Trades Up, Here Is Why
July 09, 2026
Via StockStory
Frequently Asked Questions
Is NeoGenomics, Inc. - Common Stock publicly traded?
Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
What exchange does NeoGenomics, Inc. - Common Stock trade on?
NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
What is the current price of NeoGenomics, Inc. - Common Stock?
The current price of NeoGenomics, Inc. - Common Stock is 16.52
When was NeoGenomics, Inc. - Common Stock last traded?
The last trade of NeoGenomics, Inc. - Common Stock was at 10/14/26 09:31 AM ET
What is the market capitalization of NeoGenomics, Inc. - Common Stock?
The market capitalization of NeoGenomics, Inc. - Common Stock is 2.03B
How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
NeoGenomics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>